{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:52:23Z","timestamp":1787331143290,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jval.2019.09.2749","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T23:02:04Z","timestamp":1575414124000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana"],"prefix":"10.1016","volume":"23","author":[{"given":"Mohamed","family":"Gad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalipso","family":"Chalkidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Asare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Gyansa","family":"Lutterodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jval.2019.09.2749_bib2","first-page":"76","article-title":"The effect of Ghana\u2019s National Health Insurance Scheme on health care utilisation","volume":"46","author":"Blanchet","year":"2012","journal-title":"Ghana Med J"},{"issue":"1","key":"10.1016\/j.jval.2019.09.2749_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-9276-10-4","article-title":"The financial protection effect of Ghana National Health Insurance Scheme: evidence from a study in two rural districts","volume":"10","author":"Nguyen","year":"2011","journal-title":"Int J Equity Health"},{"issue":"2","key":"10.1016\/j.jval.2019.09.2749_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1377\/hlthaff.2015.1079","article-title":"Gavi\u2019s transition policy: moving from development assistance to domestic financing of immunization programs","volume":"35","author":"Kallenberg","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.jval.2019.09.2749_bib12","unstructured":"Groom G. Final report: iDSI learning review: Ghana. https:\/\/doi.org\/10.7490\/f1000research.1116868.1. Published 2019. Accessed June 26,\u00a02019."},{"key":"10.1016\/j.jval.2019.09.2749_bib13","series-title":"Standard Treatment Guidelines","year":"2010"},{"issue":"5","key":"10.1016\/j.jval.2019.09.2749_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijpp.12263","article-title":"Evaluation of a pharmacist-led hypertension preventative and detection service in the Ghanaian community pharmacy: an exploratory study","volume":"24","author":"Marfo","year":"2016","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.jval.2019.09.2749_bib15","author":"Smith"},{"issue":"9859","key":"10.1016\/j.jval.2019.09.2749_bib17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2019.09.2749_bib19","series-title":"2010 Population & Housing Census: Summary Report of Final Results","year":"2012"},{"key":"10.1016\/j.jval.2019.09.2749_bib20","series-title":". Ghana Demographic and Health Survey 2014 (GDHS)","year":"2015"},{"issue":"10022","key":"10.1016\/j.jval.2019.09.2749_bib21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jval.2019.09.2749_bib22","doi-asserted-by":"crossref","first-page":"e65174","DOI":"10.1371\/journal.pone.0065174","article-title":"The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2019.09.2749_bib23","doi-asserted-by":"crossref","first-page":"b880","DOI":"10.1136\/bmj.b880","article-title":"Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore","volume":"338","author":"Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"issue":"7659","key":"10.1016\/j.jval.2019.09.2749_bib24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.jval.2019.09.2749_bib26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","article-title":"Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics","volume":"118","author":"Johnson","year":"2008","journal-title":"Circulation"},{"issue":"9557","key":"10.1016\/j.jval.2019.09.2749_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jval.2019.09.2749_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-141-8-200410190-00009","article-title":"Systematic review: antihypertensive drug therapy in black patients","volume":"141","author":"Brewster","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2019.09.2749_bib29","series-title":"National Health Insurance Scheme Tariffs for Secondary Care Hospitals\u2014Public","year":"2013"},{"key":"10.1016\/j.jval.2019.09.2749_bib30","series-title":"National Health Insurance Scheme Tariffs for Secondary Care Hospitals\u2014Private","year":"2013"},{"key":"10.1016\/j.jval.2019.09.2749_bib31","series-title":"National Health Insurance Scheme Tariffs for Tertiary Hospitals","year":"2013"},{"issue":"11","key":"10.1016\/j.jval.2019.09.2749_bib32","doi-asserted-by":"crossref","first-page":"e0165151","DOI":"10.1371\/journal.pone.0165151","article-title":"A\u00a0review of the National Health Insurance Scheme in Ghana: what are the sustainability threats and prospects?","volume":"11","author":"Alhassan","year":"2016","journal-title":"Plos One"},{"issue":"11","key":"10.1016\/j.jval.2019.09.2749_bib34","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global\u00a0Burden of Disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jval.2019.09.2749_bib35","author":"Wilkinson"},{"key":"10.1016\/j.jval.2019.09.2749_bib36","volume":"No. 34","year":"2006"},{"issue":"8","key":"10.1016\/j.jval.2019.09.2749_bib37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-level cost-effectiveness thresholds: initial estimates and the need for further research","volume":"19","author":"Woods","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2019.09.2749_bib38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1365-3156.2012.03021.x","article-title":"Costs, effects and cost-effectiveness of breast cancer control in Ghana","volume":"17","author":"Zelle","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jval.2019.09.2749_bib42","series-title":"Hypertension: Management of Hypertension in Adults in Primary Care (Partial Update of NICE Clinical Guideline 18). NICE Clinical Guideline 34","year":"2006"},{"key":"10.1016\/j.jval.2019.09.2749_bib44","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.13180.1","article-title":"Health technology assessment capacity development in low- and middle-income countries: experiences from the international units of HITAP and NICE","volume":"6","author":"Tantivess","year":"2017","journal-title":"F1000Research"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519351319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519351319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:18:06Z","timestamp":1761095886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519351319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1098301519351319"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2019.09.2749","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2019.09.2749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}